Omalizumab for treatment of chronic urticaria: A review of effective dose
Omalizumab or Xolair®, a humanized anti-IgE monoclonal antibody, is effective and well-tolerated in patients with chronic spontaneous urticaria refractory to H1 antihistamines. The web search of several databases, including PubMed, EMBASE, Scopus, Google, SID, Magiran, and Irandoc, led to the select...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mazandaran University of Medical Sciences
2019-03-01
|
| Series: | Pharmaceutical and Biomedical Research |
| Subjects: | |
| Online Access: | http://pbr.mazums.ac.ir/article-1-218-en.html |